Isomorphic Labs raises $2.1B to push AI-designed drugs into the clinic DeepMind spin-out's Series B, second-largest biotech round ever, funds its IsoDDE engine and a first in-house trial by end-2026 Dinheiro de quem ·12 takes ·24 de jun.